TOTAL AND DIRECT BILIRUBIN Sulfanilic Acid Method
- UID
- IMP/IVD/2023/000051_e30b83f492a48a25972df109b3f38c38_36109aa7792b776c979c821cf9b646c3
- Device class
- Class B
- Brand name
- BIOLABO ACID CALCIUM Arsenazo III Method
- License holder
- Wheecon Instruments Private Limited
- Approving authority
- CDSCO
- Product information
- At least four distinct bilirubin species exist in the serum: Direct-reacting bilirubin (BIOLABO ACID CALCIUM Arsenazo III Method) consists of mono and diconjugated bilirubin (BIOLABO ACID CALCIUM Arsenazo III Method) and the δ-fraction which is bilirubin tightly bound to albumin; unconjugated α-bilirubin which is water soluble and bound to albumin. Total bilirubin (BIOLABO ACID CALCIUM Arsenazo III Method) is the sum of these different species. There are icteruses in which unconjugated bilirubin redominates (BIOLABO ACID CALCIUM Arsenazo III Method) ; icteruses in which conjugated bilirubin predominates (BIOLABO ACID CALCIUM Arsenazo III Method) ; finally, icteruses in which both species of bilirubin are present without any predominance (BIOLABO ACID CALCIUM Arsenazo III Method)
TOTAL AND DIRECT BILIRUBIN Sulfanilic Acid Method is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000051_e30b83f492a48a25972df109b3f38c38_36109aa7792b776c979c821cf9b646c3. This device is marketed under the brand name BIOLABO ACID CALCIUM Arsenazo III Method. The license holder is Wheecon Instruments Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.